87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Urine test uses 'zombie' cell proteins for early detection of lung cancer

Urine test uses 'zombie' cell proteins for early detection of lung cancer

Credit: Pixabay/CC0 Public DomainScientists in the United Kingdom have created a world-first urine test that could indicate the first possible signs of lung cancer.Lung cancer is the third most common

Urine test uses 'zombie' cell proteins for early detection of lung cancer

Credit: Pixabay/CC0 Public DomainScientists in the United Kingdom have created a world-first urine test that could indicate the first possible signs of lung cancer.Lung cancer is the third most common
Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x
Opioids interfere with cancer immunotherapy, but another type of drug could help

Opioids interfere with cancer immunotherapy, but another type of drug could help

byUniversity of PittsburghCredit: Etatics Inc. from PexelsOpioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of

Opioids interfere with cancer immunotherapy, but another type of drug could help

byUniversity of PittsburghCredit: Etatics Inc. from PexelsOpioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of
Colorectal cancer risk factors important to consider for rescreening interval

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C
Detroit cancer center unveils new device for treating liver cancer at home

Detroit cancer center unveils new device for treating liver cancer at home

by Julia CardiCredit: Unsplash/CC0 Public DomainA new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann Karmanos Cancer Institute announce

Detroit cancer center unveils new device for treating liver cancer at home

by Julia CardiCredit: Unsplash/CC0 Public DomainA new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann Karmanos Cancer Institute announce
New toolkit to support the collection of cancer-patient-reported outcome measures

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac
Overcoming glioblastoma resistance to chemotherapy

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &
Proof-of-concept study bioengineers therapeutics for improved cancer treatment

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut
Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si
Researchers design novel immunotherapy for brain cancer

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm